Purdue Pharma is prepared to settle more than 2,000 opioid-related lawsuits for $10 billion to $12 billion, sources told NBC News.
The news service cited sources familiar with an Aug. 20 meeting where the settlements were discussed.
The attorneys general of at least 10 states as well as the plaintiffs' attorneys were at the meeting with David Sackler, who was a board member at Purdue, according to the report.
Purdue, the producer of OxyContin, has been accused in the lawsuits of using deceptive sales practices to help market painkillers.
Tuesday's report comes one day after an Oklahoma judge found Johnson & Johnson (JNJ) - Get Report responsible for helping fuel the opioid crisis in the state and ordered the health-care giant to pay $572 million.
Johnson & Johnson said it would appeal that decision. But the company's stock rose on Tuesday because many on Wall Street were expecting it to have to pay at least $1.5 billion, according to Jefferies analyst Jared Holz.
RealMoney details which public companies are exposed to opioid litigation as states seek restitution for the human cost of the crisis.
Save 57% With Our Labor Day Sale. Join Jim Cramer's Action Alerts PLUS investment club to become a smarter investor! Click here to sign up!